Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001454789-13-000004
Filing Date
2013-11-15
Accepted
2013-11-15 16:01:34
Documents
1
Effectiveness Date
2013-11-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8123
  Complete submission text file 0001454789-13-000004.txt   9220
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE 14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE 14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-206457 | Film No.: 131223983